Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterNo recent work listed

Klaus Felix

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9825-2684; OpenAlex author ID A5080981497. Sources: OpenAlex.

Their work

Papers
16 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
36
Papers, trials and grants by year

2011: 1 paper · 2012: 4 papers · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 4 papers · 2017: 1 paper · 2018: 3 papers · 2019: none · 2020: 1 paper

Papers 16

  1. Novel Autoantibody Signatures in Sera of Patients with Pancreatic Cancer, Chronic Pancreatitis and Autoimmune Pancreatitis: A Protein Microarray Profiling Appr… Last author DOI 10.3390/ijms21072403↗
  2. Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000966↗
  3. Endogenous CHRNA7-ligand SLURP1 as a potential tumor suppressor and anti-nicotinic factor in pancreatic cancer. Co-author DOI 10.18632/oncotarget.24312↗
  4. Overcoming chemoresistance in pancreatic cancer cells: role of the bitter taste receptor T2R10. Co-author DOI 10.7150/jca.21803↗
  5. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s12967-017-1227-3↗
  6. Differential Diagnosis of Autoimmune Pancreatitis From Pancreatic Cancer by Analysis of Serum Gelatinase Levels. Co-author DOI 10.1097/mpa.0000000000000576↗
  7. Identification of Novel Serum Autoantibodies for Differential Diagnosis of Autoimmune Pancreatitis and Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000647↗
  8. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for panc… Last author DOI 10.1186/s12951-016-0236-3↗
  9. Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor Progression. Co-author DOI 10.7150/ijbs.14996↗
  10. Targeted diagnostic magnetic nanoparticles for medical imaging of pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2015.07.017↗
  11. Serum protein signatures differentiating autoimmune pancreatitis versus pancreatic cancer. Co-author DOI 10.1371/journal.pone.0082755↗
  12. Expression of galectin-3 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s12253-011-9444-1↗
  13. Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer. Co-author DOI 10.1186/1471-2407-12-226↗
  14. Altered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validation. Co-author DOI 10.1371/journal.pone.0046908↗
  15. Growth inhibition of pancreatic cancer by experimental treatment with 4-phenylbutyrate is associated with increased expression of Connexin 43. Co-author DOI 10.3727/096504012x13477145152959↗
  16. Identification of serum proteins involved in pancreatic cancer cachexia. Co-author DOI 10.1016/j.lfs.2010.11.011↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Matthias M. Gaida · 7 shared papers, 2011–2018 · strength 0.47
  2. Oliver Strobel · 5 shared papers, 2017–2020 · strength 0.41
  3. Thilo Hackert · 6 shared papers, 2012–2018 · strength 0.38
  4. Jens Werner · 7 shared papers, 2011–2016 · strength 0.30
  5. Sophie Dobiasch · 4 shared papers, 2015–2018 · strength 0.23
  6. Nathalia A. Giese · 4 shared papers, 2011–2018 · strength 0.22
  7. Andrea S. Bauer · 2 shared papers, 2018–2020 · strength 0.17
  8. Sahar Ghassem‐Zadeh · 2 shared papers, 2017–2020 · strength 0.17
  9. Jean‐Louis Frossard · 2 shared papers, 2017–2020 · strength 0.17
  10. Ghislain Opdenakker · 2 shared papers, 2016 · strength 0.11
  11. M. Neulinger · 1 shared paper, 2020 · strength 0.10
  12. Masaru Yoshida · 1 shared paper, 2020 · strength 0.10
  13. Jörg D. Hoheisel · 1 shared paper, 2020 · strength 0.10
  14. Louisa Stern · 1 shared paper, 2018 · strength 0.09
  15. Lars Grenacher · 2 shared papers, 2015–2016 · strength 0.09
  16. Liron Limor Israel · 2 shared papers, 2015–2016 · strength 0.09
  17. Svitlana P. Grekova · 1 shared paper, 2018 · strength 0.07
  18. Verena M. Throm · 1 shared paper, 2018 · strength 0.07
  19. Dmitriy I. Dovzhanskiy · 2 shared papers, 2012 · strength 0.06
  20. Markus Wolfgang Büchler · 2 shared papers, 2011–2012 · strength 0.05
  21. Mauro Comes Franchini · 1 shared paper, 2016 · strength 0.05
  22. Ina Rosenberger · 1 shared paper, 2015 · strength 0.04
  23. María Jiménez-González · 1 shared paper, 2015 · strength 0.04
  24. Werner Hartwig · 1 shared paper, 2012 · strength 0.03
  25. Jens Martin Werner · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.